04.01.19
In the 2018 financial year, the Hartmann Group, one of the leading international providers of medical and hygiene products, achieved an increase in sales of 2.9% and an EBIT of €123.2 million ($138.2 million) despite a challenging environment.
The Hartmann Group was able to increase group sales within Germany (+1.6%, organic +1.9%), as well as in other European markets (+4.9%, organic +3.3%). In Germany, the Wound Management and Infection Management segments developed particularly well; in the other European markets, the Wound and Incontinence Management segments recorded strong development. The regions outside of Europe recorded a decline in sales (-2.8%, organic +1.3%) as a result of exchange rates.
Within the Incontinence Management segment, sales increased by 4.3% to €693.7 million ($778.1 million). The incontinence brand Lindor, acquired in 2017, contributed to this growth thanks to its strength in the Spanish and Portuguese market. Among the product lines, the pants from MoliCare Mobile and the skincare line MoliCare Skin enjoyed a growing level of customer acceptance.
Sales within the Wound Management segment rose by 3.6% to €474.2 million ($531.9 million), driven by the focus on innovative and high-margin ranges. Here, a two-figure sales plus was recorded by superabsorbent wound dressings and the Hydro Therapy treatment concept. An encouraging rise in sales revenues was also recorded by the Mediset pre-assembled wound treatment procedure tray.
In 2018, the Infection Management segment achieved growth in sales of 2.6% to €505.5 million ($567 million), which, among other things, was driven by higher sales volumes for customized surgical procedure trays and specific single-use procedure trays for patient care. The single-use surgical instruments, surgical gloves and SterilliumMed, a core element of the hand disinfection portfolio, also recorded dynamic growth.
The Hartmann Group was able to increase group sales within Germany (+1.6%, organic +1.9%), as well as in other European markets (+4.9%, organic +3.3%). In Germany, the Wound Management and Infection Management segments developed particularly well; in the other European markets, the Wound and Incontinence Management segments recorded strong development. The regions outside of Europe recorded a decline in sales (-2.8%, organic +1.3%) as a result of exchange rates.
Within the Incontinence Management segment, sales increased by 4.3% to €693.7 million ($778.1 million). The incontinence brand Lindor, acquired in 2017, contributed to this growth thanks to its strength in the Spanish and Portuguese market. Among the product lines, the pants from MoliCare Mobile and the skincare line MoliCare Skin enjoyed a growing level of customer acceptance.
Sales within the Wound Management segment rose by 3.6% to €474.2 million ($531.9 million), driven by the focus on innovative and high-margin ranges. Here, a two-figure sales plus was recorded by superabsorbent wound dressings and the Hydro Therapy treatment concept. An encouraging rise in sales revenues was also recorded by the Mediset pre-assembled wound treatment procedure tray.
In 2018, the Infection Management segment achieved growth in sales of 2.6% to €505.5 million ($567 million), which, among other things, was driven by higher sales volumes for customized surgical procedure trays and specific single-use procedure trays for patient care. The single-use surgical instruments, surgical gloves and SterilliumMed, a core element of the hand disinfection portfolio, also recorded dynamic growth.
